OTC - ACTIVE INGREDIENT SECTION
Pyrithione Zinc 1.8%
maxxam dermaCare Pre-Shampoo Scalp Treatment
- Manufacturer
- Huizhou Bomei Cosmetic Co., Ltd.
- Effective date
- 2021-12-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:24:58
Label at a glance#
Productmaxxam dermaCare Pre-Shampoo Scalp Treatment
Active ingredientPYRITHIONE ZINC
Label structure8 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
Water (Aqua), Cocamidopropyl Hydroxysultaine, Disodium Laureth Sulfosuccinate, Sodium Lauroyl Glutamate, Sodium Methyl Cocoyl Taurate, Zinc Pyrithione, Cocamide MIPA, Glycol Distearate , Decyl Glucoside , Glycerin, Silk Amino Acids, Acrylates Copolymer , Aloe Barbadensis Leaf Extract, Hydroxypropyltrimonium Hydrolyzed Wheat Protein, Chamomilla Recutita (Matricaria) Flower Extract, PEG-150 Pentaerythrityl Tetrastearate, Guar Hydroxypropyltrimonium Chloride, Divinyldimethicone/ Dimethicone Copolymer, Polyquatemium-10, Pro+N2pylene Glycol, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Phenoxyethanol, Fragrance (Partum), Allantoin, Tetrasodium EDTA, Ctlric Acid, PEG-7 Glyceryl Cocoate, Amodimethicone, Panthenol, Cetrimonium Chloride, Camellia Sinensis Seed Oil, Methylchloroisothiazolinone, Methylisothiazolinone
DOSAGE & ADMINISTRATION SECTION
Use: Anti-dandruff
Directions: Use once or twice a week on your scalp, beneath your head of hair only. Squeeze a 1/8 oz. of shampoo into your palm (size of half dollar). Massage into scalp. Leave on scalp for 1-2 minutes then rinse thoroughly. Maxxam DermaCare is for the scalp only; it is not intended to cleanse your head of hair. After treatment, use your regular Maxxam Shampoo and Conditioner to cleanse and hydrate your head of hair.
INDICATIONS & USAGE SECTION
Use: Anti-dandruff
Directions: Use once or twice a week on your scalp, beneath your head of hair only. Squeeze a 1/8 oz. of shampoo into your palm (size of half dollar). Massage into scalp. Leave on scalp for 1-2 minutes then rinse thoroughly. Maxxam DermaCare is for the scalp only; it is not intended to cleanse your head of hair. After treatment, use your regular Maxxam Shampoo and Conditioner to cleanse and hydrate your head of hair.
WARNINGS SECTION
WARNINGS
- For external use only
- When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
- Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as direct.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
OTC - PURPOSE SECTION
Anti-dandruff
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- maxxam dermaCare Pre-Shampoo Scalp Treatment
- pyrithione zinc shampoo
- COCO MONOISOPROPANOLAMIDE
- GLYCERIN
- CHAMOMILE
- PEG-150 PENTAERYTHRITYL TETRASTEARATE
- GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (1.7 SUBSTITUENTS PER SACCHARIDE)
- CAMELLIA SINENSIS SEED OIL
- METHYLISOTHIAZOLINONE
- AMINO ACIDS, SILK
- ALOE VERA LEAF
- EDETATE SODIUM
- EDETIC ACID
- PEG-7 GLYCERYL COCOATE
- CETRIMONIUM CHLORIDE
- METHYLCHLOROISOTHIAZOLINONE
- PHENOXYETHANOL
- ALLANTOIN
- CITRIC ACID MONOHYDRATE
- PANTHENOL
- WATER
- COCAMIDOPROPYL HYDROXYSULTAINE
- DISODIUM LAURETH SULFOSUCCINATE
- SODIUM LAUROYL GLUTAMATE
- SODIUM METHYL COCOYL TAURATE
- GLYCOL DISTEARATE
- DECYL GLUCOSIDE
- BUTYL ACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID COPOLYMER (18000 MW)
- PROPYLENE GLYCOL
- DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE)
- AMINO ACIDS, HAIR KERATIN
- POLYQUATERNIUM-10 (400 CPS AT 2%)
- HYDROLYZED WHEAT PROTEIN (ENZYMATIC, 3000 MW)
- AMODIMETHICONE (800 CST)
- PYRITHIONE ZINC
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72505-006 | 72505-006-08 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d22d24d3-66b9-9b22-e053-2a95a90a6506 | 74201f64-af30-9f38-e053-2991aa0a90e6 | 2021-12-02 | Warnings | d22d24d3-66b9-9b22-e053-2a95a90a6506 74201f64-af30-9f38-e053-2991aa0a90e6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.